Abstract
The management of patients with inhibitors is the greatest challenge facing haemophilia health professionals. Immune tolerance induction (ITI) can be successful in eliminating the inhibitor in the majority of patients, provided it is started soon after the inhibitor develops and the titre of the inhibitor is <10 BU at commencement of ITI. Acute bleeding is treated using one of two bypassing agents, which exhibit similar efficacy and safety. Surgery in inhibitor patients is challenging and should only be carried out in experienced centres. © 2012 Blackwell Publishing Ltd.
Author supplied keywords
Cite
CITATION STYLE
Makris, M., Hay, C. R. M., Gringeri, A., & D’Oiron, R. (2012). How I treat inhibitors in haemophilia. Haemophilia, 18(SUPPL.4), 48–53. https://doi.org/10.1111/j.1365-2516.2012.02829.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.